Publications by authors named "C Reynet"

Claim this Profile
S
SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1.
Lisa S Bertram, Daniel Black, Paul H Briner, Rosemary Chatfield, Andrew Cooke, Christine Reynet

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesity.
Matthew Ct Fyfe, James G McCormack, Hilary A Overton, Martin J Procter, Christine Reynet

Expert Opin Drug Discov· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity.
H A Overton, M C T Fyfe, C Reynet

Br J Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
J G Horswill, U Bali, S Shaaban, J F Keily, P Jeevaratnam, C Reynet

Br J Pharmacol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions.
M C T Fyfe, J R White, A Taylor, R Chatfield, E Wargent, C Reynet

Diabetologia· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis